Rituximab vs Technetium Tc 99M Medronate

## Rituximab vs Technetium Tc 99M Medronate: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Technetium Tc 99M Medronate**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Technetium Tc 99M Medronate — N/A.

## Chemical Properties

**Type**: Rituximab — Antibody; Technetium Tc 99M Medronate — Small molecule.